Soluble form of CTLA-4 is a good predictor for tumor recurrence after radiofrequency ablation in hepatocellular carcinoma patients.
Wei TengWen-Juei JengWei-Ting ChenChen-Chun LinChun-Yen LinShi-Ming LinI-Shyan SheenPublished in: Cancer medicine (2022)
sCTLA-4 level is a good predictor for early HCC recurrence with higher levels indicating susceptibility to early LR, but protecting from early IHM.